As we previously reported, JAMP sought leave to commence an application against Janssen under the abuse of dominance provisions of the Competition Act (the Act), relating to ustekinumab (Janssen’s ...
JAMP Pharma's new head office on Boucherville, Québec. (c) Bénédicte Brocard (CNW Group/Fonds de solidarité FTQ) Boucherville, Quebec – October 25, 2016 — JAMP Pharma, a Boucherville based generic ...
The MarketWatch News Department was not involved in the creation of this content. A new generic option of Enzalutamide, an oncology medication used for the treatment of certain stages of prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results